FDA Inspection 921199 — Mary Bird Perkins Cancer Center
The FDA completed an inspection of Mary Bird Perkins Cancer Center on April 2, 2015 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 2, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Baton Rouge, LA (United States)